Ceftaroline Fosamil for the Treatment of Methicillin-Resistant Staphylococcus Aureus Bacteremia: A Real-World Comparative Clinical Outcomes Study
Abstract Background and Objective Methicillin-resistant Staphylococcus aureus (MRSA) bacteremia results in substantial morbidity and mortality. As current treatments often lead to unsatisfactory outcomes, evidence guiding alternative treatment options is needed. This study evaluated real-world clini...
Saved in:
Main Authors: | Jennifer Hammond (Author), Michael Benigno (Author), Nataly Bleibdrey (Author), Wajeeha Ansari (Author), Jennifer L. Nguyen (Author) |
---|---|
Format: | Book |
Published: |
Adis, Springer Healthcare,
2024-04-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
A Mini-Review on Ceftaroline in Bacteremia Patients with Methicillin-Resistant <i>Staphylococcus aureus</i> (MRSA) Infections
by: Nicole Lounsbury, et al.
Published: (2019) -
Experience with ceftaroline for treatment of methicillin-resistant Staphylococcus aureus pneumonia in a community hospital
by: Apurwa Karki, et al.
Published: (2017) -
In vitro activity of ceftaroline: A novel antibiotic against methicillin-resistant Staphylococcus aureus
by: Vaishali Gaikwad, et al.
Published: (2016) -
Ceftaroline fosamil for the treatment of community-acquired bacterial pneumonia in the intensive care unit
by: Maggiore C, et al.
Published: (2015) -
Ceftaroline Fosamil for the Empiric Treatment of Hospitalized Adults with cSSTI: An Economic Analysis from the Perspective of the Spanish National Health System
by: Torres A, et al.
Published: (2022)